Phathom Pharmaceuticals, Inc.PHATNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
74.52%
↑ 132% above average
Average (30q)
-229.86%
Historical baseline
Range
High:92.43%
Low:-6671.13%
Volatility
-2942.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 74.52% |
| Q2 2025 | 24.02% |
| Q1 2025 | -32.73% |
| Q4 2024 | 16.07% |
| Q3 2024 | 8.41% |
| Q2 2024 | -10.50% |
| Q1 2024 | -0.11% |
| Q4 2023 | -95.95% |
| Q3 2023 | -12.49% |
| Q2 2023 | -5.40% |
| Q1 2023 | 35.52% |
| Q4 2022 | -9.67% |
| Q3 2022 | 6.25% |
| Q2 2022 | -19.67% |
| Q1 2022 | -14.73% |
| Q4 2021 | 0.29% |
| Q3 2021 | 6.18% |
| Q2 2021 | -5.17% |
| Q1 2021 | 35.96% |
| Q4 2020 | -59.73% |
| Q3 2020 | -63.98% |
| Q2 2020 | 1.74% |
| Q1 2020 | -29.83% |
| Q4 2019 | -149.81% |
| Q3 2019 | 92.43% |
| Q2 2019 | -6671.13% |
| Q1 2019 | -171.84% |
| Q4 2018 | -68.28% |
| Q3 2018 | -5.93% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |